Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 5, 2024British Journal of Clinical PharmacologyOpen Access

Pharmacokinetic‐pharmacodynamic modelling and simulation of methotrexate dosing in patients with rheumatoid arthritis

View Full Paper
Ask AI
Bookmark
Share

Authors

JTJiun Ming TanRURichard N. UptonDFDavid J. R. Foster

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tan et al. (2024) studied this question.

synapsesocial.com/papers/68e613c2b6db6435875a6847https://doi.org/10.1111/bcp.16158
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Analysis of methotrexate use practice in patients with rheumatoid and psoriatic arthritis2024
  2. 2Development and validation of a clinical scoring system for the prediction of methotrexate treatment response in rheumatoid arthritis patients: a multicenter real-world study2026
  3. 3Clinical predictors of response to methotrexate in patients with rheumatoid arthritis: A systematic review2026
  4. 4AB0646 COMPARISON OF METHOTOREXATE-POLYGLUTAMATE CONCENTRATIONS IN RED BLOOD CELLS AND PBMCS IN PATIENTS WITH RA2024
  5. 5#284 Risk of dose-dependent methotrexate therapy on renal functions in patients with rheumatoid arthritis2024